Get the Stockscreener App
19.63
10.34%
1.84
After Hours:
19.62
-0.010
-0.05%
Pulse Biosciences Inc stock is traded at $19.63, with a volume of 135.76K.
It is up +10.34% in the last 24 hours and down -3.21% over the past month.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
See More
Previous Close:
$17.79
Open:
$18.07
24h Volume:
135.76K
Relative Volume:
0.84
Market Cap:
$1.21B
Revenue:
-
Net Income/Loss:
$-42.21M
P/E Ratio:
-22.06
EPS:
-0.89
Net Cash Flow:
$-33.16M
1W Performance:
+8.93%
1M Performance:
-3.21%
6M Performance:
+70.10%
1Y Performance:
+94.55%
1-Day Range:
$18.07
$19.78
1-Week Range:
$16.97
$19.78
52-Week Range:
$6.595
$22.69
Pulse Biosciences Inc Stock (PLSE) Company Profile
Name
Pulse Biosciences Inc
Sector
Industry
Phone
510-906-4600
Address
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
19.63 | 1.21B | 0 | -42.21M | -33.16M | -0.89 |
|
ISRG
Intuitive Surgical Inc
|
535.29 | 190.66B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
228.46 | 66.26B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.06 | 41.58B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.67 | 34.01B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
335.56 | 24.30B | 2.88B | 499.60M | 321.60M | 6.74 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-27-21 | Initiated | Stephens | Overweight |
| Mar-11-21 | Initiated | Maxim Group | Buy |
| Jan-26-21 | Reiterated | H.C. Wainwright | Buy |
| May-12-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-14-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-25-19 | Initiated | H.C. Wainwright | Buy |
View All
Pulse Biosciences Inc Stock (PLSE) Latest News
Pulse Biosciences (NASDAQ:PLSE) Trading 6.1% HigherShould You Buy? - MarketBeat
Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
Pulse Biosciences to Present Nano-PFA Technology at J.P. Morgan Healthcare Conference 2025 - StockTitan
Geode Capital Management LLC Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Barclays PLC Buys 23,738 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Purchased by Geode Capital Management LLC - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Upgraded to "Sell" at StockNews.com - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Rating Increased to Sell at StockNews.com - Defense World
Franklin Resources Inc. Buys New Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
(PLSE) Investment Report - Stock Traders Daily
State Street Corp Increases Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - MarketBeat
State Street Corp Buys 69,696 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ:PLSE) Trading Down 2.2%Time to Sell? - MarketBeat
Pulse Biosciences: Constructive On Nano-Pulse Assets (NASDAQ:PLSE) - Seeking Alpha
Pulse Biosciences (NASDAQ:PLSE) Stock Rating Upgraded by StockNews.com - Defense World
Pulse Biosciences (NASDAQ:PLSE) Shares Gap UpShould You Buy? - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Upgraded at StockNews.com - MarketBeat
Pulse Biosciences Triggers $66M Warrant Redemption After Stock Price Surge Above $16.50 - StockTitan
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New $588,000 Investment in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
(PLSE) On The My Stocks Page - Stock Traders Daily
Insider Selling: Pulse Biosciences, Inc. (NASDAQ:PLSE) CEO Sells 50,000 Shares of Stock - MarketBeat
Pulse Biosciences' former CEO Barrett Burke Thomas sells $871,000 in stock - Investing.com Canada
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants - Business Wire
Pulse Biosciences' Major Shareholder Exercises $58.4M in Warrants, Boosts Ownership to 70% - StockTitan
Insider Trading Insights: Key Buys and Sells from Pulse Biosciences, Centene and More - mediahousepress
Pulse Biosciences director Robert Duggan purchases $949,298 in stock By Investing.com - Investing.com UK
Pulse Biosciences, Inc. (NASDAQ:PLSE) Director Buys $949,298.08 in Stock - MarketBeat
Pulse Biosciences director Robert Duggan purchases $949,298 in stock - Investing.com
Pulse Biosciences (NASDAQ:PLSE) Trading 5.3% HigherStill a Buy? - MarketBeat
Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery - BioSpace
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up on Insider Buying Activity - Defense World
Charles Schwab Investment Management Inc. Has $2.60 Million Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up Following Insider Buying Activity - MarketBeat
Robert Duggan Spends US$972k On Pulse Biosciences Stock - Yahoo Finance
Executive Co-Chairman of Pulse Biosciences Robert Duggan Buys More Stock - Simply Wall St
Insider Buying: Pulse Biosciences, Inc. (NASDAQ:PLSE) Director Purchases 56,054 Shares of Stock - MarketBeat
StockNews.com Upgrades Pulse Biosciences (NASDAQ:PLSE) to Sell - Defense World
Pulse Biosciences director Robert Duggan buys $972,343 in stock By Investing.com - Investing.com Canada
Positive Data Presented for Pulse Biosciences’ nano-PFA Tech - MPO-mag
Top Key Executive Robert Duggan, Pulse Biosciences, Inc.'s (NASDAQ:PLSE) largest shareholder sees value of holdings go down 13% after recent drop - Yahoo Finance
Pulse Biosciences Welcomes New Executive Team Members - MPO-mag
(PLSE) Long Term Investment Analysis - Stock Traders Daily
Pulse Biosciences (NASDAQ:PLSE) Stock Price Up 7.4%What's Next? - MarketBeat
Pulse Biosciences announces CEO departure and interim leadership By Investing.com - Investing.com Australia
Pulse Biosciences announces CEO departure and interim leadership - Investing.com
Pulse Biosciences CEO Resigns Amid Leadership Transition - TipRanks
Pulse Biosciences, Inc. Announces Chief Executive Officer Changes - Marketscreener.com
Pulse Biosciences Inc Stock (PLSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pulse Biosciences Inc Stock (PLSE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DUGGAN ROBERT W | Director |
Dec 13 '24 |
Buy |
17.18 |
55,256 |
949,298 |
42,328,717 |
| DUGGAN ROBERT W | Director |
Dec 12 '24 |
Buy |
17.13 |
45,404 |
777,771 |
42,273,461 |
| DUGGAN ROBERT W | Director |
Dec 11 '24 |
Buy |
17.35 |
56,054 |
972,344 |
42,228,057 |
| Barrett Burke Thomas | President and CEO |
May 20 '24 |
Buy |
8.56 |
10,000 |
85,600 |
10,000 |
2.64%
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):